Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281481033> ?p ?o ?g. }
- W4281481033 endingPage "3315" @default.
- W4281481033 startingPage "3308" @default.
- W4281481033 abstract "Bone loss is a major issue in patients affected by Duchenne muscular dystrophy (DMD), a rare musculoskeletal disorder, particularly in those treated with glucocorticoids (GCs). We aimed to assess the effectiveness of neridronate in terms of bone mineral density (BMD) changes in this population.We retrospectively reviewed the records of patients affected by DMD receiving GCs referred to our outpatient from 2015 to 2020. All patients were treated with an intramuscular (IM) injection of neridronate (25 mg every month). Bone density was measured at the lumbar spine (LS; L1-L4 tract) using dual-energy x-ray absorptiometry (DXA) (GE Lunar), no more than 4 weeks before (T0) and after 1 year from neridronate treatment (T1).Eight boys with DMD were included with a mean age at diagnosis of 4.75 ± 2.81 years. Six of them were non-ambulant and two of them had previous low-trauma fractures (a distal femur fracture and a vertebral compression fracture, respectively). All patients were receiving deflazacort [median duration of therapy 11.5 years (interquartile range 2-25)]. At the DXA evaluation (T0), the mean L1-L4 BMD value was 0.716 ± 0.164 g/cm2. Six patients (75%) showed an L1-L4 Z-score height-adjusted of less than - 2. The mean age of neridronate initiation was 18.87 ± 6.81 years. All patients were supplemented with calcium carbonate and vitamin D at baseline. After 12 months of treatment (T1), the mean L1-L4 BMD value was 0.685 ± 0.190 g/cm2. Seven patients (87.5%) showed an L1-L4 Z-score of less than - 2. Changes in LS BMD and Z-score were not significant between T0 and T1 in our cohort (p = 0.674 and p = 0.208, respectively) as well as among non-ambulant patients with DMD without previous fragility fractures.In this study, we reported for the first time that neridronate may slow bone loss in GC-treated patients with DMD at 1-year follow-up." @default.
- W4281481033 created "2022-05-26" @default.
- W4281481033 creator A5018836715 @default.
- W4281481033 creator A5033382999 @default.
- W4281481033 creator A5039731619 @default.
- W4281481033 creator A5052079243 @default.
- W4281481033 creator A5074666735 @default.
- W4281481033 date "2022-05-25" @default.
- W4281481033 modified "2023-10-05" @default.
- W4281481033 title "Effectiveness of Neridronate in the Management of Bone Loss in Patients with Duchenne Muscular Dystrophy: Results from a Pilot Study" @default.
- W4281481033 cites W1484734787 @default.
- W4281481033 cites W1972974851 @default.
- W4281481033 cites W1974923890 @default.
- W4281481033 cites W1989866265 @default.
- W4281481033 cites W1990714410 @default.
- W4281481033 cites W1997932979 @default.
- W4281481033 cites W2025317204 @default.
- W4281481033 cites W2037333809 @default.
- W4281481033 cites W2046050937 @default.
- W4281481033 cites W2046369760 @default.
- W4281481033 cites W2046815985 @default.
- W4281481033 cites W2074974557 @default.
- W4281481033 cites W2105511156 @default.
- W4281481033 cites W2118553609 @default.
- W4281481033 cites W2396039069 @default.
- W4281481033 cites W2462564436 @default.
- W4281481033 cites W2608444169 @default.
- W4281481033 cites W2731725622 @default.
- W4281481033 cites W2765840669 @default.
- W4281481033 cites W2784992484 @default.
- W4281481033 cites W2895677686 @default.
- W4281481033 cites W2921753663 @default.
- W4281481033 cites W2944555482 @default.
- W4281481033 cites W2991610770 @default.
- W4281481033 cites W3004592820 @default.
- W4281481033 cites W3035708703 @default.
- W4281481033 cites W3113279132 @default.
- W4281481033 cites W3131782536 @default.
- W4281481033 cites W3146846567 @default.
- W4281481033 cites W3157108592 @default.
- W4281481033 cites W3198763911 @default.
- W4281481033 cites W4206940312 @default.
- W4281481033 cites W4245244655 @default.
- W4281481033 doi "https://doi.org/10.1007/s12325-022-02179-1" @default.
- W4281481033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35614293" @default.
- W4281481033 hasPublicationYear "2022" @default.
- W4281481033 type Work @default.
- W4281481033 citedByCount "2" @default.
- W4281481033 countsByYear W42814810332022 @default.
- W4281481033 countsByYear W42814810332023 @default.
- W4281481033 crossrefType "journal-article" @default.
- W4281481033 hasAuthorship W4281481033A5018836715 @default.
- W4281481033 hasAuthorship W4281481033A5033382999 @default.
- W4281481033 hasAuthorship W4281481033A5039731619 @default.
- W4281481033 hasAuthorship W4281481033A5052079243 @default.
- W4281481033 hasAuthorship W4281481033A5074666735 @default.
- W4281481033 hasBestOaLocation W42814810331 @default.
- W4281481033 hasConcept C119060515 @default.
- W4281481033 hasConcept C126322002 @default.
- W4281481033 hasConcept C141071460 @default.
- W4281481033 hasConcept C2776376305 @default.
- W4281481033 hasConcept C2776541429 @default.
- W4281481033 hasConcept C2776886416 @default.
- W4281481033 hasConcept C2778943923 @default.
- W4281481033 hasConcept C2779030066 @default.
- W4281481033 hasConcept C2779329777 @default.
- W4281481033 hasConcept C2780554211 @default.
- W4281481033 hasConcept C2781440623 @default.
- W4281481033 hasConcept C2908647359 @default.
- W4281481033 hasConcept C71924100 @default.
- W4281481033 hasConcept C99454951 @default.
- W4281481033 hasConceptScore W4281481033C119060515 @default.
- W4281481033 hasConceptScore W4281481033C126322002 @default.
- W4281481033 hasConceptScore W4281481033C141071460 @default.
- W4281481033 hasConceptScore W4281481033C2776376305 @default.
- W4281481033 hasConceptScore W4281481033C2776541429 @default.
- W4281481033 hasConceptScore W4281481033C2776886416 @default.
- W4281481033 hasConceptScore W4281481033C2778943923 @default.
- W4281481033 hasConceptScore W4281481033C2779030066 @default.
- W4281481033 hasConceptScore W4281481033C2779329777 @default.
- W4281481033 hasConceptScore W4281481033C2780554211 @default.
- W4281481033 hasConceptScore W4281481033C2781440623 @default.
- W4281481033 hasConceptScore W4281481033C2908647359 @default.
- W4281481033 hasConceptScore W4281481033C71924100 @default.
- W4281481033 hasConceptScore W4281481033C99454951 @default.
- W4281481033 hasIssue "7" @default.
- W4281481033 hasLocation W42814810331 @default.
- W4281481033 hasLocation W42814810332 @default.
- W4281481033 hasLocation W42814810333 @default.
- W4281481033 hasOpenAccess W4281481033 @default.
- W4281481033 hasPrimaryLocation W42814810331 @default.
- W4281481033 hasRelatedWork W2063631614 @default.
- W4281481033 hasRelatedWork W2107495478 @default.
- W4281481033 hasRelatedWork W2357911571 @default.
- W4281481033 hasRelatedWork W2360555619 @default.
- W4281481033 hasRelatedWork W2395351319 @default.
- W4281481033 hasRelatedWork W2412783504 @default.
- W4281481033 hasRelatedWork W2671531964 @default.